What is the prevalence of Aspergillosis?

How many people does Aspergillosis affect? Does it have the same prevalence in men and women? And in the different countries?

Aspergillosis is a fungal infection caused by the Aspergillus fungus. It can affect individuals with weakened immune systems, such as those with HIV/AIDS or undergoing organ transplantation. The prevalence of Aspergillosis varies depending on the population and geographic location. Invasive forms of the disease are relatively rare, affecting an estimated 3.5 to 6.4 cases per 100,000 individuals globally. However, it is important to note that non-invasive forms of Aspergillosis, such as allergic bronchopulmonary aspergillosis, are more common. Early diagnosis and appropriate treatment are crucial in managing this condition.

Aspergillosis is a fungal infection caused by the Aspergillus fungus. It primarily affects the respiratory system, but can also spread to other organs in individuals with weakened immune systems. The prevalence of Aspergillosis varies depending on several factors such as geographical location, population demographics, and underlying health conditions.

In general, Aspergillosis is considered to be a relatively rare infection. However, it is important to note that certain subtypes of Aspergillosis, such as invasive pulmonary aspergillosis (IPA), can be more prevalent in specific high-risk groups.

For example, individuals with compromised immune systems, such as those with HIV/AIDS, organ transplant recipients, or patients undergoing chemotherapy, are more susceptible to developing Aspergillosis. Additionally, individuals with chronic lung diseases like asthma or cystic fibrosis may also be at an increased risk.

While precise prevalence rates can vary, studies estimate that the overall incidence of invasive Aspergillosis ranges from 3 to 13 cases per 100,000 population per year. However, these figures may be higher in certain high-risk populations.

Early diagnosis and appropriate treatment are crucial in managing Aspergillosis. If you suspect you may have Aspergillosis or have concerns about your respiratory health, it is important to consult a healthcare professional for proper evaluation and guidance.

Diseasemaps

I find it difficult to answer this question as there are different strains of Aspergillosis, and also that it not a notifiable disease. My consultant has suggested that of my strain there are approx 750 cases in the UK but I don't really know,
I belong to a forum and from the correspondents it would appear that there are more women than men, but this could well be that women are more ready to communicate but I see no logical reason why there should be any discrepancy, I have a gut feeling that there are more adults than children, but this could be due to non diagnosis.

Posted Oct 18, 2017 by Vaughan 2500

I was told it affects one in 10,000 people

Posted Oct 21, 2017 by Boni 1450

it is all over the world, GPs still do not diagnose people with a aspergillosis condition even when they have occurring chest problems, third world are effected the most due to lack of treatments getting to them and Aids sufferers have practically no immune system

Posted Nov 9, 2017 by Sam 2500

Affects people with asthma bronchal and sinus problems not apparent male or female statistics.

Posted Aug 14, 2018 by StuartMcKelvie 4050

The prevalence is between 1 and 15% of patients with cystic fibrosis, also there is a prevalence with a percentage of asthma sufferers.

Posted Aug 8, 2019 by Patricia Fletcher 2500

https://www.gaffi.org/why/burden-of-disease-maps/

Posted Oct 16, 2019 by GAtherton 3100

much more prevalent than you would think - especially Africa and Asia

Posted Oct 17, 2019 by Linda Galbraith 2500

Allergic bronchopulmonary aspergillosis (ABPA) likely affects between 1 and 15% of cystic fibrosis patients. One study calculated that 2.5% of adults who have asthma also have ABPA, which is approximately 4.8 million people worldwide.
There is a male predominance

Posted Oct 19, 2019 by Pam Mars 2500

ABPA affects 10% of asthmatics.

Posted Feb 15, 2020 by Peta 3110